Clinical trial
Mexican Registry of Dyslipidemia in Patients at High and Very High Risk of Atherosclerotic Cardiovascular Disease and the Use of an Application to Achieve Dyslipidemic Treatment Goals - REMEXDIS-IMSS
NCT05542719 is registered in ClinicalTrials.gov with Coordinación de Investigación en Salud, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mexican Registry of Dyslipidemia in Patients at High and Very High Risk of Atherosclerotic Cardiovascular Disease and the Use of an Application to Achieve Dyslipidemic Treatment Goals - REMEXDIS-IMSS
- Lead sponsor
- Coordinación de Investigación en Salud, Mexico
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 4, 2022
- Completion date
- December 31, 2024
- Enrollment
- 13,166 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease with mention of arteriosclerosis, dyslipidemias, secondary prevention